These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 11163231)

  • 1. Mechanism of measles virus-induced suppression of inflammatory immune responses.
    Marie JC; Kehren J; Trescol-Biémont MC; Evlashev A; Valentin H; Walzer T; Tedone R; Loveland B; Nicolas JF; Rabourdin-Combe C; Horvat B
    Immunity; 2001 Jan; 14(1):69-79. PubMed ID: 11163231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficient major histocompatibility complex class II-restricted presentation of measles virus relies on hemagglutinin-mediated targeting to its cellular receptor human CD46 expressed by murine B cells.
    Gerlier D; Trescol-Biémont MC; Varior-Krishnan G; Naniche D; Fugier-Vivier I; Rabourdin-Combe C
    J Exp Med; 1994 Jan; 179(1):353-8. PubMed ID: 8270880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measles virus exploits dendritic cells to suppress CD4+ T-cell proliferation via expression of surface viral glycoproteins independently of T-cell trans-infection.
    Dubois B; Lamy PJ; Chemin K; Lachaux A; Kaiserlian D
    Cell Immunol; 2001 Dec; 214(2):173-83. PubMed ID: 12088416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficient MHC class II-restricted presentation of measles virus to T cells relies on its targeting to its cellular receptor human CD46 and involves an endosomal pathway.
    Gerlier D; Trescol-Biémont MC; Varior-Krishnan G; Naniche D; Fugier-Vivier I; Rabourdin-Combe C
    Cell Biol Int; 1994 May; 18(5):315-20. PubMed ID: 8049676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced MHC class II-restricted presentation of measles virus (MV) hemagglutinin in transgenic mice expressing human MV receptor CD46.
    Rivailler P; Trescol-Biémont MC; Gimenez C; Rabourdin-Combe C; Horvat B
    Eur J Immunol; 1998 Apr; 28(4):1301-14. PubMed ID: 9565370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measles virus-induced promotion of dendritic cell maturation by soluble mediators does not overcome the immunosuppressive activity of viral glycoproteins on the cell surface.
    Klagge IM; ter Meulen V; Schneider-Schaulies S
    Eur J Immunol; 2000 Oct; 30(10):2741-50. PubMed ID: 11069053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional modulation of human macrophages through CD46 (measles virus receptor): production of IL-12 p40 and nitric oxide in association with recruitment of protein-tyrosine phosphatase SHP-1 to CD46.
    Kurita-Taniguchi M; Fukui A; Hazeki K; Hirano A; Tsuji S; Matsumoto M; Watanabe M; Ueda S; Seya T
    J Immunol; 2000 Nov; 165(9):5143-52. PubMed ID: 11046046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Linking innate and acquired immunity: divergent role of CD46 cytoplasmic domains in T cell induced inflammation.
    Marie JC; Astier AL; Rivailler P; Rabourdin-Combe C; Wild TF; Horvat B
    Nat Immunol; 2002 Jul; 3(7):659-66. PubMed ID: 12055630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ex vivo analysis of cytotoxic T lymphocytes to measles antigens during infection and after vaccination in Gambian children.
    Jaye A; Magnusen AF; Sadiq AD; Corrah T; Whittle HC
    J Clin Invest; 1998 Dec; 102(11):1969-77. PubMed ID: 9835622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formaldehyde inactivation of measles virus abolishes CD46-dependent presentation of nucleoprotein to murine class I-restricted CTLs but not to class II-restricted helper T cells.
    Cardoso AI; Beauverger P; Gerlier D; Wild TF; Rabourdin-Combe C
    Virology; 1995 Sep; 212(1):255-8. PubMed ID: 7676641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective immunity elicited by measles vaccine exerts anti-tumor effects on measles virus hemagglutinin gene-modified cancer cells in a mouse model.
    Qi Y; Xing K; Zhang L; Zhao F; Yao M; Hu A; Wu X
    J Cancer Res Clin Oncol; 2018 Oct; 144(10):1945-1957. PubMed ID: 30090962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantification of measles virus by a virus receptor-dependent and haemagglutinin-specific T cell stimulation assay.
    Trescol-Biémont MC; Leonov S; Rabourdin-Combe C; Gerlier D
    J Immunol Methods; 1995 Dec; 187(2):253-8. PubMed ID: 7499884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measles virus infects and suppresses proliferation of T lymphocytes from transgenic mice bearing human signaling lymphocytic activation molecule.
    Hahm B; Arbour N; Naniche D; Homann D; Manchester M; Oldstone MB
    J Virol; 2003 Mar; 77(6):3505-15. PubMed ID: 12610126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measles virus infects human dendritic cells and blocks their allostimulatory properties for CD4+ T cells.
    Grosjean I; Caux C; Bella C; Berger I; Wild F; Banchereau J; Kaiserlian D
    J Exp Med; 1997 Sep; 186(6):801-12. PubMed ID: 9294135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Receptor (CD46)- and replication-mediated interleukin-6 induction by measles virus in human astrocytoma cells.
    Ghali M; Schneider-Schaulies J
    J Neurovirol; 1998 Oct; 4(5):521-30. PubMed ID: 9839649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of measles virus glycoproteins with the surface of uninfected peripheral blood lymphocytes induces immunosuppression in vitro.
    Schlender J; Schnorr JJ; Spielhoffer P; Cathomen T; Cattaneo R; Billeter MA; ter Meulen V; Schneider-Schaulies S
    Proc Natl Acad Sci U S A; 1996 Nov; 93(23):13194-9. PubMed ID: 8917567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Receptor usage and differential downregulation of CD46 by measles virus wild-type and vaccine strains.
    Schneider-Schaulies J; Schnorr JJ; Brinckmann U; Dunster LM; Baczko K; Liebert UG; Schneider-Schaulies S; ter Meulen V
    Proc Natl Acad Sci U S A; 1995 Apr; 92(9):3943-7. PubMed ID: 7732009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD4+ T cells regulate CD8+ T cell-mediated cutaneous immune responses by restricting effector T cell development through a Fas ligand-dependent mechanism.
    Gorbachev AV; Fairchild RL
    J Immunol; 2004 Feb; 172(4):2286-95. PubMed ID: 14764697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of suppression of cell-mediated immunity by measles virus.
    Karp CL; Wysocka M; Wahl LM; Ahearn JM; Cuomo PJ; Sherry B; Trinchieri G; Griffin DE
    Science; 1996 Jul; 273(5272):228-31. PubMed ID: 8662504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measles virus-induced immunosuppression in SLAM knock-in mice.
    Koga R; Ohno S; Ikegame S; Yanagi Y
    J Virol; 2010 May; 84(10):5360-7. PubMed ID: 20200244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.